Synthesis,Processing and the Effect of Thermal Treatment on the Solubility,Antioxidant Potential and Cytocompatibility of Y2O3 and CeO2 doped SiO2-SrO-Na2O Glass-Ceramics
Restricted accessResearch articleFirst published online July, 2022
Synthesis,Processing and the Effect of Thermal Treatment on the Solubility,Antioxidant Potential and Cytocompatibility of Y2O3 and CeO2 doped SiO2-SrO-Na2O Glass-Ceramics
Thermal treatment of a 0.52SiO2-0.24SrO-0.24-xNa2O-xMO glass-ceramic series (where x = 0.08 and MO = Y2O3 or CeO2) was conducted in order to synthesize yttrium (Y3+) and cerium (Ce3+) crystalline species that may act as radical oxygen specie (ROS) scavengers. The prominent phase for the Control is a sodium-strontium-silicate while the experimental glass-ceramics (HY, YCe, and HCe) present sodium-Y/Ce-silicate and oxide phases. Disk shrinkage during thermal processing ranges from 1–7% for Control, HY, YCe, and HCe in both diameter and thickness. Solubility studies determined that the release of Si4+ and Na+ are greatest from the Control disks which peaks at 1550 µg/mL. Release from the Y3+ and Ce3+ glass-ceramics reached 320 µg/mL for Si4+ and 630 µg/mL for Na+. The range of antioxidant capacity (ABTS assay) for all samples was 0.31–3.9 mMTE. No significant reduction in MC 3T3 Osteoblast cell viability was observed for any composition tested.
TohdaCKuboyamaT. Current and future therapeutic strategies for functional repair of spinal cord injury. Pharma Therap2011; 132(1): 57–71.
2.
BartholdiDSchwabME. Degeneration and regeneration of axons in the lesioned spinal cord. Phys Rev1996; 76(2): 319–370.
3.
StichelCCMüllerHW. Experimental strategies to promote axonal regeneration after traumatic central nervous system injury. Prog Neurobio1998; 56(2): 119–148.
4.
DuganLSensiSCanzonieroL, et al.Mitochondrial production of reactive oxygen species in cortical neurons following exposure to N-methyl-D-aspartate. J Neurosci1995; 15(10): 6377–6388.
5.
TymianskiCHTatorM. Normal and abnormal calcium homeostasis in neurons: a basis for the pathophysiology of traumatic and ischemic central nervous system injury. Neurosur1996; 38(6): 1176–1195.
6.
ChoiDW. Calcium and excitotoxic neuronal injury. Ann New York Acad Sci1994; 747(1): 162–171.
7.
WolfJAStysPKLusardiT, et al.Traumatic axonal injury induces calcium influx modulated by tetrodotoxin-sensitive sodium channels. J Neurosci2001; 21(6).1923–1930.
8.
LoPachinRMLehningEJ. Mechanism of calcium entry during axon injury and degeneration. Tox App Pharma1997; 143(2): 233–244.
9.
SchubertDDarguschRRaitanoJ, et al.Cerium and yttrium oxide nanoparticles are neuroprotective. Biochem Biophy Res Comm2006; 342(1): 86–91.
10.
HenchLL. The story of bioglass. J Mat Sci:mat Med2006; 17: 967–978.
11.
JonesJR. Review of bioactive glass: from hench to hybrids. Acta Biomater2013; 9: 4457–4486.
12.
RahamanMNDayDESonny BalB, et al.Bioactive glass in tissue engineering. Acta Biomater2014; 7: 2355–2373.
13.
ChenQZThompsonIDBoccacciniAR. 45S5 Bioglass®-derived glass-ceramic scaffolds for bone tissue engineering. Biomat2006; 27(11): 2414–2425.
14.
VargasGEMesonesRVBretcanuO, et al.Biocompatibility and bone mineralization potential of 45S5 Bioglass®-derived glass-ceramic scaffolds in chick embryos. Acta Biomater2009; 5(1): 374–380.
15.
WrenAWCoughlanALaffirFR, et al.Comparison of a SiO2-CaO-ZnO-SrO glass polyalkenoate cement to commercial dental materials: glass structure and physical properties. J Mat Sci:mat Med2013; 24(2): 271–280.
16.
WrenAWCoughlanAGermanMJ, et al.Comparison of a SiO2-CaO-ZnO-SrO glass polyalkenoate cement to commercial dental materials: ion release, biocompatibility and antibacterial properties. J Mat Sci:mat Med2013: 24(9): 2255–2264.
17.
WrenAWBoydDThorntonR, et al.Antibacterial properties of a tri-sodium citrate modified glass polyalkenoate cement. J Biomed Mat Res B: app Biomat90-B(2)2009; 90: 700–709.
18.
da Costa GuimaraesCMorallesMCRoberto MartinelliJ. Monte carlo simulation of liver cancer treatment with 166Ho-loaded glass microspheres. Rad Phys Chem2014; 95: 185–187.
19.
BortotMBPrastaloSPradoM. Production and characterization of glass microspheres for hepatic cancer treatment. Proc Mat Sci2012; 1(0): 351–358.
20.
KokuboTTakadamaH. How useful is SBF in predicting in vivo bone bioactivity?Biomat2006; 27(15): 2907–2915.
21.
HoppeAGüldalNSBoccacciniAR. A review of the biological response to ionic dissolution products from bioactive glasses and glass-ceramics. Biomat2011; 32(11): 2757–2774.
22.
Saffarian TousiNVeltenMFBishopTJ, et al.Combinatorial effect of Si4+, Ca2+, and Mg2+ released from bioactive glasses on osteoblast osteocalcin expression and biomineralization. Mat Sci Eng C2013; 33(5): 2757–2765.
23.
HenchLL. Genetic design of bioactive glass. J Euro Cer Soc2009; 29(7): 1257–1265.
24.
PlacekLMKeenanTJCoughlanA, et al.Investigating the effect of glass ion release on the cytocompatibility, antibacterial efficacy and antioxidant activity Y2O3 /CeO2 doped SiO2-SrO-Na2O glass extract. Biomed Glasses2018; 4: 32–44.
25.
PlacekLMWrenAW. Cytocompatibility of Y2O3 and CeO2 containing bioactive glasses to aid in spinal cord recovery. In: 41st Annual Northeast Bioengineering Conference (NEBEC), Troy, NY, 17–19 April 2015. https://web.northeastern.edu/nebec14/contributed-presentations/
26.
LefebvreLChevalierJGremillardL, et al.Structural transformations of bioactive glass 45S5 with thermal treatments. Acta Mater2007; 55(10): 3305–3313.
27.
MasseraJHupaL. Influence of SrO substitution for CaO on the properties of bioactive glass S53P4. J Mat Sci:mat Med2014; 25(3): 657–668.
28.
MasseraJHupaLHupaM. Influence of the partial substitution of CaO with MgO on the thermal properties and in vitro reactivity of the bioactive glass S53P4. J Non-crys Sol2012; 358(18–19): 2701–2707.
29.
WrenAWCoughlanASmaleKE, et al.Fabrication of CaO–NaO–SiO2/TiO2 scaffolds for surgical applications. J Mat Sci:mat Med2012; 23(12): 2881–2891.
30.
El-KheshenAAKhaliafaFASaadEA, et al.Effect of Al2O3 addition on bioactivity, thermal and mechanical properties of some bioactive glasses. Cer Int2008; 34(7): 1667–1673.
31.
FredholmYCKarpukhinaNBrauerDS, et al.Influence of strontium for calcium substitution in bioactive glasses on degradation, ion release and apatite formation. J Roy Soc Inter2012; 9(70): 880–889.
32.
GentlemanEFredholmYCJellG, et al.The effects of strontium-substituted bioactive glasses on osteoblasts and osteoclasts. In Vitro. Biomat2010; 31(14): 3949–3956.
33.
MariePJAmmannPBoivinG, et al.Mechanisms of action and therapeutic potential of strontium in bone. Calc Tis Int2001; 69(3): 121–129.
34.
PlacekLMKeenanTJLaffirF, et al.Characterization of Y2O3 and CeO2 doped SiO2-SrO-Na2O bioactive glasses. Biomed Glasses2015; 1: 159–172.
35.
BainsMHallED. Antioxidant therapies in traumatic brain and spinal cord injury. Bioch Biophy Acta - Mol Bas Dis2012; 1822(5): 675–684.
36.
EstevezAYPritchardSHarperK, et al.Neuroprotective mechanisms of cerium oxide nanoparticles in a mouse hippocampal brain slice model of ischemia. Free Rad Bio Med2011; 51(6): 1155–1163.
37.
PlacekLMKeenanTJWrenAW. Bioactivity of Y2O3 and CeO2 doped SiO2-SrO-Na2O glass-ceramics. J Biomat App2016; 3(2): 165–180.
38.
BretcanuOChatzistavrouXParaskevopoulosK, et al. Sintering and crystallisation of 45S5 bioglass® powder. J Euro Cer Soc2009; 29(16): 3299–3306.
39.
LiZ-PMoriTYeF, et al.Cerium-reduction-induced defects clustering, ordering, and associated microstructure evolution in yttrium-doped ceria. J Phys Chem C2012; 116(9): 5435–5443.
40.
ElBatalHAAzoozMAKhalilEMA, et al.Characterization of some bioglass–ceramics. Mat Chem Phys2003; 80(3): 599–609.
41.
PlettinckSChouLWollastR. Kinetics and mechanisms of dissolution of silica at room temperature and pressure. Mineral Mag A1994; 58: 728–729.
42.
Dent GlasserLSKataokaN. The chemistry of ‘alkali-aggregate’ reaction. Cem Con Res1981; 11(1): 1–9.
43.
FlemingBA. Kinetics of reaction between silicic acid and amorphous silica surfaces in NaCl solutions. J Coll Int Sci1986; 110(1): 40–64.
44.
MandalRGuoACChaudharyKK, et al.Multi-platform characterization of the human cerebrospinal fluid metabolome: a comprehensive and quantitative update. Gen Med2012; 4(4): 38–38.
45.
VerberckmoesSCDe BroeMED'HaesePC. Dose-dependent effects of strontium on osteoblast function and mineralization. Kid Int2003; 64(2): 534–543.
46.
Pors NielsenS. The biological role of strontium. Bone2004; 35(3): 583–588.
47.
O'DonnellMDCandarliogluPLMillerCA, et al.Materials characterisation and cytotoxic assessment of strontium-substituted bioactive glasses for bone regeneration. J Mat Chem2010; 20(40): 8934–8941.
48.
CacainaDYlanenHHupaM, et al.Study of yttrium containing bioactive glasses behaviour in simulated body fluid. J Mat Sci:mat Med2006; 17(8): 709–716.
49.
LeonelliCLusvardiGMalavasiG, et al.Synthesis and characterization of cerium-doped glasses and in vitro evaluation of bioactivity. J Non-crys Sol2003; 316(2–3): 198–216.
50.
ChristieJKTiloccaA. Aluminosilicate glasses as yttrium vectors for in situ radiotherapy: understanding composition-durability effects through molecular dynamics simulations. Chem Mat2010; 22(12): 3725–3734.
51.
DuJKokouLRygelJL, et al.Structure of cerium phosphate glasses: molecular dynamics simulation. J Amer Cer Soc2011; 94(8): 2393–2401.
52.
GreenbergSASinclairD. The polymerization of silicic acid. J Phys Chem1955; 59(5): 435–440.
53.
GotoK. Effect of pH on polymerization of silicic acid. J Phys Chem1956; 60(7): 1007–1008.
54.
CoradinTLivageJ. Effect of some amino acids and peptides on silicic acid polymerization. Coll Sur B2001; 21(4): 329–336.
55.
ChanSH. A review on solubility and polymerization of silica. Geother1989; 18(1): 49–56.
